Communicating the External Beam Radiation Experience (CEBRE): Perceived Benefits of a Graphic Narrative Patient Education Tool.
Journal
Practical radiation oncology
ISSN: 1879-8519
Titre abrégé: Pract Radiat Oncol
Pays: United States
ID NLM: 101558279
Informations de publication
Date de publication:
Historique:
received:
29
05
2019
revised:
15
08
2019
accepted:
04
09
2019
pubmed:
15
9
2019
medline:
16
3
2021
entrez:
15
9
2019
Statut:
ppublish
Résumé
Current radiation oncology patient education materials exceed national readability recommendations. A graphic narrative educational tool, the Communicating the External Beam Radiation Experience (CEBRE) discussion guide, was developed to facilitate patient-provider communication. A pilot study evaluated perceived benefits of CEBRE for patients and physicians. CEBRE was designed through a collaboration between physicians and designers. Designers interviewed patients, family members, and the clinical team. Interviews were coded for themes, leading to the design principles that drove the design of CEBRE, including a graphic narrative component. CEBRE explains the radiation therapy care path. Readability was measured using the Flesch-Kincaid test. Patients receiving radiation therapy or in follow-up and practicing radiation oncologists reviewed CEBRE and completed independent surveys. Each survey included modified versions of the Systems Usability Score (SUS) and Spielberger State-Trait Anxiety Inventory (STAI) short form, along with questions unique to CEBRE. Likert-type scores are reported as median (interquartile range). CEBRE scores at a 5.4 Flesch-Kincaid grade level. Thirty-four patients and 15 radiation oncologists completed surveys. Patients had completed a high school/general equivalency degree (18%), a 2-year degree or some college (50%), or at least 4 years of college (32%). Patient and physician responses were concordant. On a scale of 1 to 5 for modified SUS and 1 to 4 for modified STAI ("strongly disagree" to "strongly agree") the SUS scores were 4 (4-5) and 4 (4-5) and STAI scores were 3 (3-4) and 3 (3-3.5) for patients and providers, respectively. This indicates CEBRE is usable and would decrease anxiety. Compared with text, the graphic narrative component of CEBRE was rated as "quite helpful" (4 [4-5]). CEBRE, a graphic narrative education tool developed through a novel collaboration between designers and radiation therapy stakeholders, is accessible for patients and practical to facilitate patient-provider discussion. Perceived benefits demonstrating high usability and the potential to decrease patient anxiety warrant further prospective investigation of CEBRE in the clinical setting.
Identifiants
pubmed: 31520767
pii: S1879-8500(19)30264-4
doi: 10.1016/j.prro.2019.09.001
pmc: PMC7064379
mid: NIHMS1539821
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e219-e226Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR000430
Pays : United States
Informations de copyright
Copyright © 2019 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.
Références
Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):1108-9
pubmed: 25832701
Med Humanit. 2013 Jun;39(1):70-1
pubmed: 23192901
Soc Sci Med. 2001 Jun;52(12):1865-78
pubmed: 11352412
Cancer. 1985 Sep 1;56(5):1056-61
pubmed: 4016697
Br J Clin Psychol. 1992 Sep;31(3):301-6
pubmed: 1393159
Eur J Cancer Care (Engl). 2019 Jan;28(1):e12911
pubmed: 30204270
BMJ. 2018 Apr 25;361:k1415
pubmed: 29695476
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Patient Educ Couns. 2007 Feb;65(2):158-65
pubmed: 16870385
Health Expect. 2007 Jun;10(2):103-7
pubmed: 17524003
BMJ. 2010 Mar 03;340:c863
pubmed: 20200064
CA Cancer J Clin. 1998 May-Jun;48(3):151-62
pubmed: 9594918
Ann Oncol. 2010 Jun;21(6):1145-1151
pubmed: 19940010
BMC Health Serv Res. 2015 Jun 27;15:249
pubmed: 26113118
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S467-72
pubmed: 22588767
Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):521-8
pubmed: 27681748
J Cancer Educ. 2013 Jun;28(2):306-13
pubmed: 23526553
CA Cancer J Clin. 2008 Sep-Oct;58(5):293-304
pubmed: 18755939
Med Care. 2007 Apr;45(4):340-9
pubmed: 17496718
Br J Clin Psychol. 1983 Nov;22 (Pt 4):245-9
pubmed: 6640176
J Med Humanit. 2008 Jun;29(2):71-88
pubmed: 18392671
J Cancer Educ. 2017 Jun;32(2):238-245
pubmed: 28138917
Med Decis Making. 1997 Jul-Sep;17(3):298-306
pubmed: 9219190
Patient Educ Couns. 2006 May;61(2):173-90
pubmed: 16122896
Psychooncology. 2003 Sep;12(6):557-66
pubmed: 12923796
Hematol Oncol Clin North Am. 2002 Jun;16(3):731-43
pubmed: 12170578
Chest. 2013 Mar;143(3):672-677
pubmed: 22814873
Clin Genitourin Cancer. 2006 Dec;5(3):219-26
pubmed: 17239276
Am J Clin Oncol. 2005 Dec;28(6):609-12
pubmed: 16317273
Cancer. 2018 Apr 15;124(8):1673-1681
pubmed: 29479673
Patient Educ Couns. 1997 Jul;31(3):245-61
pubmed: 9277247
BMJ. 2009 Feb 26;338:b541
pubmed: 19246544
CMAJ. 1995 May 1;152(9):1423-33
pubmed: 7728691